Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of CEPH and non-CEPH lymphoblast cell lines in pharmacogenetic studies.

Pharmacogenomics - 1 Apr 2005

Shukla Sunita J, Dolan M Eileen

Abstract excerpt

A long-term goal of pharmacogenomic research is the design of individualized therapy based on the genomic sequence of the patient in order to maximize response and minimize adverse drug reactions. Identifying genetic variants that predict drug response is challenging because drug responses reflect not only properties intrinsic to the target cell, but also host metabolic factors. One model that is currently being...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotics, Antineoplastic
Share to Cell Line, Transformed
Share to Cell Transformation, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cisplatin

Share to Drug-Related Side Effects and Adverse Reactions

Share to Herpesvirus 4, Human

Share to Lymphocytes

Share to Mitomycin

Source

Identifiers

PMID: 16013961
DOI: 10.1517/14622416.6.3.303

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of CEPH and non-CEPH lymphoblast cell lines in pharmacogenetic studies.PMID 16013961Read ↗

Lymphoblastoid Cell Lines in Pharmacogenomic Discovery and Clinical TranslationSemantic proximity Read ↗

Lymphoblastoid cell lines models of drug response: successes and lessons from this pharmacogenomic model.Semantic proximity Read ↗

Use of cell lines in the investigation of pharmacogenetic loci.Semantic proximity Read ↗

Genetic analysis of human traits in vitro: drug response and gene expression in lymphoblastoid cell lines.Semantic proximity Read ↗

Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines.Semantic proximity Read ↗

The use of genomic information to optimize cancer chemotherapy.Semantic proximity Read ↗

Application of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics.Semantic proximity Read ↗

Impact of the 1000 genomes project on the next wave of pharmacogenomic discovery.Semantic proximity Read ↗

CEPH individuals are representative of the European American population: implications for pharmacogenetics.Semantic proximity Read ↗

PACdb: a database for cell-based pharmacogenomics.Semantic proximity Read ↗

Genome-wide discovery of loci influencing chemotherapy cytotoxicitySemantic proximity Read ↗

A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.